Trial intelligence / Profile preview

Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test

NCT05634473Unknown

Sponsor
Chia Tai-Tianqing Pharmaceutical Group
Start
Dec 2022
Primary completion
Feb 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Open-label, single-arm trial of methacholine in asthma, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Primary endpoints: Sensitivity analysis at Day 1, Specificity Analysis at Day 1 and 5 more. Status: unknown.

02

Drugs

methacholine
03

Conditions

asthma

Beyond the preview

Go deeper on NCT05634473.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05634473.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call